Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Tune Therapeutics

News headline image
Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026
From Tune Therapeutics
Via Business Wire
News headline image
Tune Therapeutics Announces Late-Breaking Oral Presentation for TUNE-401 at European Association for the Study of the Liver Congress 2026
From Tune Therapeutics
Via Business Wire
News headline image
Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board
From Tune Therapeutics
Via Business Wire
News headline image
Tune Therapeutics Completes Over $175M in Series B Financing to Advance Field-Leading Epigenome Editing Programs
From Tune Therapeutics
Via Business Wire
News headline image
Tune Therapeutics Receives Approval to Initiate Clinical Trial in Hong Kong for HepB Epigenetic Silencer
From Tune Therapeutics
Via Business Wire
News headline image
AASLD 2024: Tune Therapeutics Shows Near-Complete HepB Virus Repression with Tune-401 Epigenetic Silencer
From Tune Therapeutics
Via Business Wire
News headline image
Tune Therapeutics Moves into Clinical Spotlight with TUNE-401: A First-in-Class Epigenetic Silencer for Hepatitis B
From Tune Therapeutics
Via Business Wire
News headline image
Tune Therapeutics Presents First Data Supporting TUNE-401: a First-in-Class Epigenetic Silencer for Hepatitis B
From Tune Therapeutics
Via Business Wire
News headline image
Tune Therapeutics Reveals Epigenetic Editing Program Targeting Hepatitis B Virus
From Tune Therapeutics
Via Business Wire
News headline image
Tune Therapeutics Unveils Breakthrough Data Showing Stable and Durable Epigenetic Regulation in Non-Human Primates
From Tune Therapeutics
Via Business Wire
News headline image
Tune Therapeutics Strengthens Leadership Team with Addition of Dr. Derek Jantz as Chief Scientific Officer and Zachary Hale as General Counsel
From Tune Therapeutics
Via Business Wire
News headline image
Tune Therapeutics Welcomes Noted Industry Leader Dr. John McHutchison to Board of Directors
From Tune Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.